Results 111 to 120 of about 17,756 (301)

What is the best management for patients who have a TIA while on aspirin therapy? [PDF]

open access: yes, 2006
Alternative antiplatelet therapy for stroke prevention is indicated for patients who experience transient ischemic attacks (TIAs) while on aspirin therapy (strength of recommendation [SOR]: A, based on 1 meta- analysis and 1 randomized controlled trial).
Ahmed, Nabila, Coffey, John B.
core  

Analysis of the structure of consumption of antiplatelet drugs in the Russian pharmaceutical market: 2014-2016

open access: yesКачественная клиническая практика, 2018
This article analyzes the volume of the Russian pharmaceutical market of antiplatelet drugs in the period 2014-2016. 80% of patients take clopidogrel generics, giving preference to Zilt®.
S. K. Zyryanov, E. V. Dumchenko
doaj  

Clinical outcomes of stents versus balloon angioplasty in non-acute coronary artery disease: A meta-analysis of randomized controlled trials [PDF]

open access: yes, 2017
Aims To evaluate whether stents as compared to balloon angioplasty reduce mortality in patients with non-acute coronary artery disease. Methods and results We identified randomized controlled trials comparing stents to balloon angioplasty for the ...
Bucher, Heiner C.   +5 more
core  

Effects of ticlopidine on pharmacokinetics of losartan and its main metabolite EXP-3174 in rats

open access: yesActa Pharmacologica Sinica, 2011
Aim:Losartan and antiplatelet agent ticlopidine can be prescribed concomitantly for prevention or therapy of cardiovascular diseases. Hence, the effects of ticlopidine on the pharmacokinetics of losartan and its active metabolite EXP-3174 were evaluated ...
Si-hyung Yang   +2 more
semanticscholar   +1 more source

Platelet Inhibition in Percutaneous Coronary Interventions [PDF]

open access: yes, 2018
: Mechanical disruption of atherosclerotic plaques at the time of percutaneous coronary intervention (PCI) is a potent stimulus for arterial thrombosis.
Roffi, Marco, Wyss, Christophe
core  

Late coronary occlusion after intracoronary brachytherapy [PDF]

open access: yes, 1999
BACKGROUND: Intracoronary brachytherapy appears to be a promising technology to prevent restenosis. Presently, limited data are available regarding the late safety of this therapeutic modality.
Cervinka, P.   +9 more
core  

Impact of clopidogrel in coronary artery bypass grafting [PDF]

open access: yes, 2017
Objective: Clopidogrel has become the standard of care to prevent thrombotic complications following cardiological interventions, in particular intracoronary stenting.
Berdat, Pascal A.   +5 more
core  

Randomized Study Of Ticlopidine On Cerebral Vasospasm Following Ruptured Aneurysm [PDF]

open access: bronze, 1981
Masafumi Mizukami   +3 more
openalex   +1 more source

Current Concepts on Antiplatelet Therapy: Focus on the Novel Thienopyridine and Non-Thienopyridine Agents

open access: yesAdvances in Hematology, 2010
Thienopyridines are a class of drug targeting the platelet adenosine diphosphate (ADP) 2 receptor. They significantly reduce platelet activity and are therefore clinically beneficial in settings where platelet activation is a key pathophysiological ...
L. Testa   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy